IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls

Scandinavian Journal of Rheumatology

Volumn 40, Issue 6, 2011, Pages 453-456

  Antonelli, A ^a   Ferri, C ^b   Ferrari, S M ^a   Mancusi, C ^a   Colaci, M ^b   Sebastiani, M ^b   Fallahi, P ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; DRUG THERAPY, COMBINATION; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83455210338     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.585349     Document Type: Article

References (16)

1. Martins EP, Fuzzi HT, Kayser C, Alarcon RT, Rocha MG, Chauffaille ML, et al. Increased chromosome damage in systemic sclerosis skin fibroblasts. Scand J Rheumatol 2010;39:398-401.
2. van Lieshout AW, Vonk MC, Bredie SJ, Joosten LB, Netea MG, van Riel PL, et al. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009;38:282-90.
3. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369-74.
4. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, et al. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis: a longitudinal study. Rheumatology 2008;47:45-9. (Pubitemid 350286260)
5. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001;27:140-6. (Pubitemid 32781022)
6. Hasegawa M, Hamaguchi Y, Yanaba K, Bouaziz JD, Uchida J, Fujimoto M, et al. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006;169:954-66. (Pubitemid 44411958)
7. Feghali CA, Bost KL, Boulware DW, Levy LS. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity 1994;17:309-18. (Pubitemid 24238337)
8. Takemura H, Suzuki H, Fujisawa H, Yuhara T, Akama T, Yamane K, et al. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. J Rheumatol 1998;25:1534-9. (Pubitemid 28364759)
9. Antonelli A, Ferri C, Ferrari SM, Colaci M, Giuggioli D, Fallahi P. Induction of CXCL10 secretion by interferon-g and tumour necrosis factor-a and its inhibition by peroxisome proliferatoractivated receptor-g agonists in cultured scleroderma fibroblasts. Br J Dermatol 2010;163:650-1.
10. Valentini G, Baroni A, Esposito K, Naclerio C, Buommino E, Farzati A, et al. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol 2001;21:210-17. (Pubitemid 32434308)
11. Kadono T, Kikuchi K, Ihn H, Takehara K, Tamaki K. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol 1998;25:296-301. (Pubitemid 28088258)
12. Zhou L, Askew D, Wu C, Gilliam AC. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 2007;127:281-92. (Pubitemid 46106903)
13. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101. (Pubitemid 350018717)
14. Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004;138:540-6. (Pubitemid 39573637)
15. Raoul JM, Verma M, Tan E, Peterson TC. Cytokines as therapeutic targets for the gastrointestinal manifestations of scleroderma. Can J Gastroenterol 2004;18:22-4. (Pubitemid 38292221)
16. Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, et al. The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. Rheumatology (Oxford) 2010;49:2408-12.